23ANDME HOLDING CO -CLASS A (ME) Stock News
NASDAQ:ME - Nasdaq - US90138Q3065 - Common Stock - Currency: USD
ME Latest News, Press Relases and Analysis
J&J sees tariff impact from exports to China more than global imports: CFO
J&J faces several headwinds at the start of the year, including patent expiry, talc litigation, and, now, tariffs.
US House committee seeks testimony from 23andMe co-founder after bankruptcy
James Comer, a Republican from Kentucky and the chairman of the House Committee on Oversight and Government Reform, sent a letter to 23andMe's Anne Wojcicki, seeking her testimony on May 6 as well as documents and information from the genomics firm. Wojcicki made multiple failed takeover bids for the company and resigned as its CEO in March. The bankruptcy filing has raised concerns about where the genetic data it collected would go.
AQR Capital Management posts Q1 returns near 10% in several funds, source says
Billionaire investor Cliff Asness's AQR Capital Management finished the first quarter with positive returns in several of its funds, said a source familiar with the matter on Tuesday. The $128 billion hedge fund returned a positive 3.4% performance in March its multi-strategy fund, Apex Strategy, finishing with a 9% first quarter return. The hedge fund's Helix Strategy which uses trend following in a diverse set of harder to access markets had a positive 3% performance for the quarter and a 4.4% in March.
These are the people who want to buy 23andMe
A genomics company, a crypto foundation, and the former CEO are all looking at this treasure trove of genetic data.
FTC concerned about privacy protections in 23andMe bankruptcy
(Reuters) -The U.S. Federal Trade Commission is concerned about the potential sale or transfer of Americans' personal information by 23andMe ancestry testing company which recently filed for bankruptcy, the agency's chairman said on Monday. Any purchaser of 23andMe assets should agree to be bound by the company's existing privacy policy, FTC Chairman Andrew Ferguson said in a letter to the U.S. trustee, a government office that oversees bankruptcies. It has said the bankruptcy process will not affect how it stores, manages or protects customer data.
23andMe’s failure shows how risky it can be to invest in a SPAC
The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations.
Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals
Stocktwits users spotted a media report about Richard Magides, the director of Singapore-based Zentree Investment and 23andMe's second-largest shareholder, expressing interest in backing a rescue effort.
Bank of America CEO Brian Moynihan expects no interest rate cuts this year
Bank of America CEO Brian Moynihan weighed in on President Donald Trump’s new auto import levies, how consumers are reacting to the administration’s tariffs and the bank’s expectations about interest rates.
5 lessons from 23andMe's tragic arc: Morning Brief
"We'll figure out profitability later" has its limits.
23andMe Confirms All Potential Buyers Must Agree to Comply With Privacy Policy and Applicable Law
Receives Court Approval for First Day Motions to Support Ongoing Business Operations
23andMe Confirms All Potential Buyers Must Agree to Comply With Privacy Policy and Applicable Law
Receives Court Approval for First Day Motions to Support Ongoing Business Operations...
Bankrupt 23andMe’s DNA Data Gets Nod for Sale as Concerns Linger
Bankrupt genetic testing firm 23andMe Holding Co. won permission from a judge to try to sell information about customers’ medical and ancestry-related data, a trove that is considered the most valuable asset in the insolvency case — and has become a source of privacy and safety concerns amid the company’s collapse.
The battle for 23andMe's DNA customer data
A bankruptcy filing by personalized genomics firm 23andMe calls into question what happens to its most valuable asset: genetic data from 15 million customers.
23andMe stock plunges following bankruptcy, CEO exit
The stock of 23andMe dropped 59% Monday after filing for federal bankruptcy protection and the exit of its CEO, a dramatic collapse for a biotech company that once dazzled Silicon Valley.
23andMe Starts Chapter 11 Process, Co-Founder Steps Down as CEO
23andMe Holding Co. has initiated bankruptcy proceedings in the US to help facilitate a sale.